Progentos Therapeutics, Inc. — Form D

Progentos Therapeutics, Inc. of WATERTOWN, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-05-17. The offering totals $68.6M, of which $68.6M was reported sold. Industry: Other.

Offering

Issuer

Officers, directors & promoters (8)

NameRoleLocation
Cassidy BlundellDirectorBoston, MA
Dmitrij HristodorovDirectorBoston, MA
Dan JanneyDirectorWatertown, MA
Christopher LooseDirectorWatertown, MA
Aleks Radovic-MorenoDirectorWatertown, MA
Marc-Olivier TurgeonDirectorWatertown, MA
Christopher LooseExecutive OfficerWatertown, MA
Sanjay MagaviExecutive OfficerWatertown, MA

More